SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-016568
Filing Date
2022-01-25
Accepted
2022-01-25 08:27:43
Documents
53
Period of Report
2022-01-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d277644d8k.htm   iXBRL 8-K 32321
2 EX-99.1 d277644dex991.htm EX-99.1 47857
3 EX-99.2 d277644dex992.htm EX-99.2 4465
7 GRAPHIC g277644ex99_1s10g1.jpg GRAPHIC 205232
8 GRAPHIC g277644ex99_1s11g1.jpg GRAPHIC 212939
9 GRAPHIC g277644ex99_1s12g1.jpg GRAPHIC 222421
10 GRAPHIC g277644ex99_1s13g1.jpg GRAPHIC 189190
11 GRAPHIC g277644ex99_1s14g1.jpg GRAPHIC 207055
12 GRAPHIC g277644ex99_1s15g1.jpg GRAPHIC 291208
13 GRAPHIC g277644ex99_1s16g1.jpg GRAPHIC 207157
14 GRAPHIC g277644ex99_1s17g1.jpg GRAPHIC 238259
15 GRAPHIC g277644ex99_1s18g1.jpg GRAPHIC 264765
16 GRAPHIC g277644ex99_1s19g1.jpg GRAPHIC 309237
17 GRAPHIC g277644ex99_1s1g1.jpg GRAPHIC 271090
18 GRAPHIC g277644ex99_1s20g1.jpg GRAPHIC 183732
19 GRAPHIC g277644ex99_1s21g1.jpg GRAPHIC 196996
20 GRAPHIC g277644ex99_1s22g1.jpg GRAPHIC 254529
21 GRAPHIC g277644ex99_1s23g1.jpg GRAPHIC 247648
22 GRAPHIC g277644ex99_1s24g1.jpg GRAPHIC 234092
23 GRAPHIC g277644ex99_1s25g1.jpg GRAPHIC 333762
24 GRAPHIC g277644ex99_1s26g1.jpg GRAPHIC 243344
25 GRAPHIC g277644ex99_1s27g1.jpg GRAPHIC 213075
26 GRAPHIC g277644ex99_1s28g1.jpg GRAPHIC 223193
27 GRAPHIC g277644ex99_1s29g1.jpg GRAPHIC 245998
28 GRAPHIC g277644ex99_1s2g1.jpg GRAPHIC 672616
29 GRAPHIC g277644ex99_1s30g1.jpg GRAPHIC 260971
30 GRAPHIC g277644ex99_1s31g1.jpg GRAPHIC 281666
31 GRAPHIC g277644ex99_1s32g1.jpg GRAPHIC 263096
32 GRAPHIC g277644ex99_1s33g1.jpg GRAPHIC 239969
33 GRAPHIC g277644ex99_1s34g1.jpg GRAPHIC 192782
34 GRAPHIC g277644ex99_1s35g1.jpg GRAPHIC 326339
35 GRAPHIC g277644ex99_1s36g1.jpg GRAPHIC 155756
36 GRAPHIC g277644ex99_1s3g1.jpg GRAPHIC 272430
37 GRAPHIC g277644ex99_1s4g1.jpg GRAPHIC 225124
38 GRAPHIC g277644ex99_1s5g1.jpg GRAPHIC 166271
39 GRAPHIC g277644ex99_1s6g1.jpg GRAPHIC 256996
40 GRAPHIC g277644ex99_1s7g1.jpg GRAPHIC 325551
41 GRAPHIC g277644ex99_1s8g1.jpg GRAPHIC 252848
42 GRAPHIC g277644ex99_1s9g1.jpg GRAPHIC 223999
43 GRAPHIC g277644ex99_2s1g1.jpg GRAPHIC 335958
44 GRAPHIC g277644ex99_2s2g1.jpg GRAPHIC 243256
45 GRAPHIC g277644ex99_2s3g1.jpg GRAPHIC 212978
  Complete submission text file 0001193125-22-016568.txt   13880759

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA spro-20220125.xsd EX-101.SCH 2885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20220125_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20220125_pre.xml EX-101.PRE 11727
47 EXTRACTED XBRL INSTANCE DOCUMENT d277644d8k_htm.xml XML 3476
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 22551176
SIC: 2834 Pharmaceutical Preparations